Ohio HB388 provides reimbursement for state employees and officials for GLP-1 drug costs.
Ohio HB388 amends the state's Revised Code to include reimbursements for out-of-pocket costs of GLP-1 drugs for state employees and elected state officials. Eligible employees must have a body mass index of at least thirty, as determined by a physician, and the drug must be approved by the FDA for chronic weight management. Reimbursements are capped at $500 for the first year and $250 for the second year, with a maximum of $2,400 over a 24-month period.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.